Targeting Interleukin-1 and Interleukin-6: The Time Has Come to Aggressively Address Residual Inflammatory Risk
published in: Journal of the American College of Cardiology
date of publication: 2020-10-01
Cites articles
There is nothing here
Article - wd:Q100502951